Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SOX2 regulates the hypothalamic-pituitary axis at multiple levels
Sujatha A. Jayakody, … , Mehul T. Dattani, Juan P. Martinez-Barbera
Sujatha A. Jayakody, … , Mehul T. Dattani, Juan P. Martinez-Barbera
Published September 4, 2012
Citation Information: J Clin Invest. 2012;122(10):3635-3646. https://doi.org/10.1172/JCI64311.
View: Text | PDF
Research Article Development

SOX2 regulates the hypothalamic-pituitary axis at multiple levels

  • Text
  • PDF
Abstract

Sex-determining region Y (SRY) box 2 (SOX2) haploinsufficiency causes a form of hypopituitarism in humans that is characterized by gonadotrophin deficiency known as hypogonadotrophic hypogonadism. Here, we conditionally deleted Sox2 in mice to investigate the pathogenesis of hypogonadotrophic hypogonadism. First, we found that absence of SOX2 in the developing Rathke pouch of conditional embryos led to severe anterior lobe hypoplasia with drastically reduced expression of the pituitary-specific transcription factor POU class 1 homeobox 1 (POU1F1) as well as severe disruption of somatotroph and thyrotroph differentiation. In contrast, corticotrophs, rostral-tip POU1F1-independent thyrotrophs, and, interestingly, lactotrophs and gonadotrophs were less affected. Second, we identified a requirement for SOX2 in normal proliferation of periluminal progenitors; in its absence, insufficient precursors were available to produce all cell lineages of the anterior pituitary. Differentiated cells derived from precursors exiting cell cycle at early stages, including corticotrophs, rostral-tip thyrotrophs, and gonadotrophs, were generated, while hormone-producing cells originating from late-born precursors, such as somatotrophs and POU1F1-dependent thyrotrophs, were severely reduced. Finally, we found that 2 previously characterized patients with SOX2 haploinsufficiency and associated hypogonadotrophic hypogonadism had a measurable response to gonadotropin-releasing hormone (GnRH) stimulation, suggesting that it is not the absence of gonadotroph differentiation, but rather the deficient hypothalamic stimulation of gonadotrophs, that underlies typical hypogonadotrophic hypogonadism.

Authors

Sujatha A. Jayakody, Cynthia L. Andoniadou, Carles Gaston-Massuet, Massimo Signore, Anna Cariboni, Pierre M. Bouloux, Paul Le Tissier, Larysa H. Pevny, Mehul T. Dattani, Juan P. Martinez-Barbera

×

Figure 5

Significant reduction of GnRH neurons in the brain and nasal regions of Hesx1Cre/+;Sox2fl/fl mutant embryos.

Options: View larger image (or click on image) Download as PowerPoint
Significant reduction of GnRH neurons in the brain and nasal regions of ...
(A and B) Specific immunostaining shows the accumulation of GnRH in the axon terminals of GnRH neurons in the median eminence (ME) of the control (A), but not the mutant hypothalamus, at late gestation (B). (C and D) Representative pictures of GnRH neurons (arrowheads) in the brain at the level of the medial preoptic area. (E) Quantitative analysis of total numbers of GnRH neurons in the brain of both genotypes at 18.5 dpc (n = 2 per genotype). (F and G) Representative pictures of migrating GnRH neurons in the nasal area (NA; arrowheads) and forebrain (FB; arrows) at 13.5 dpc. (H) Quantitative analysis of total numbers of GnRH neurons in the heads of embryos of both genotypes (n = 3 per genotype; *P = 0.011; Student’s t test). (I–L) At 12.5 dpc, GnRH neurons are detected around the OE (arrowheads) and are migrating toward the forebrain (arrows) in the control embryo (I and K) (n = 2). There is an evident reduction in the mutant embryo (J and L) (n = 2). Scale bars: 100 μm; 10 μm (insets).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts